Impact Factor
3.89
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.85
1,729 total citations
h5-index
45
h5 depth signal
Cited share
83.3%
404 of 485
Total citations
1,729
Citation footprint
Metric signal
4.11
External metric anchor
Self-citation
2.8%
48 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
485
France
416
Spain
320
Italy
236
United States
218
Citing Fields of Research
Antibiotic & Antibacterial Agents
1,604
Bacteriology
483
Virology
270
Clinical Laboratory Science
235
Fungal Pathogenesis
180
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,829
Articles tracked across the journal lifetime
Indexed publication set
485
404 cited publications
Last 12 months
394
32.8 publications/month
Open access share
41.1%
162 OA publications in the last year
Leading citing country
China
485 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
1,604 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v7n1,Feb. 1988-
v7n1,Feb. 1988-
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Issuing & Sponsoring Bodies
Contributor
European Society of Clinical Microbiology
Broad Categories
Communicable Diseases
Microbiology
Antibiotic & Antibacterial Agents
MeSH Descriptors
Communicable Diseases
Microbiology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s10096-026-05699-8
Open DOI
ST20 Staphylococcus aureus causing suppurative cervical lymphadenitis in an extremely low-birth-weight infant
03
DOI 10.1007/s10096-026-05690-3
Open DOI
Retraction Note: Scalp eschar and neck lymphadenopathy after tick bite: an emerging syndrome with multiple causes
04
DOI 10.1007/s10096-026-05702-2
Open DOI
Desensitisation protocol for ethambutol in the treatment of Mycobacterium avium complex pulmonary disease
Background: Ethambutol is a key component of treatment for Mycobacterium avium complex pulmonary disease (MAC-PD), primarily through suppression of macrolide resistance. However, adverse drug reactions frequently lead to treatment interr...
05
06
DOI 10.1007/s10096-026-05694-z
Open DOI
Sex-related differences in clinical characteristics, management, and outcomes of Enterococcus faecalis bloodstream infection
Objectives: To evaluate whether clinical characteristics and outcomes of patients with Enterococcus faecalis bloodstream infection (EF-BSI) differ by biological sex. Methods: Quasi-experimental study conducted at two hospitals, comprisin...
07
DOI 10.1007/s10096-026-05695-y
Open DOI
First report of proven Fusarium brachygibbosum sinusitis in a paediatric patient with acute myeloblastic leukaemia
Purpose: Fusarium brachygibbosum is an environmental mould belonging to the Fusarium sambucinum species complex (FSAMSC) and is only exceptionally reported as a human pathogen. Invasive fusariosis is a recognized complication in patients...
08
09
10
Bibliographical & Catalog Notes
Also issued online.